SmartPilot connected add-on for prefilled UnoPen
Vision
Our vision is to transform the proven prefilled UnoPen into a connected therapy platform that combines drug delivery, patient support, titration support, and real-world data generation to improve treatment outcomes.
Not only a device accessory, SmartPilot is designed as part of a broader digital health ecosystem connecting patients, healthcare professionals, payers, and pharmaceutical companies.
What it offers
- Wireless tracking of injection date, time and success
Bluetooth®-based tracking provides injection data, supporting advanced adherence monitoring. - Advanced patient guidance and drug identification
Step-by-step guidance throughout the injection process, with NFC-based identification of the combination product label to increase patient safety. - Integration within broader digital health ecosystems
Can be integrated into clinical trials and commercial patient monitoring programs through web-based interfaces.
Market background
Selfcare, home-based treatment, and direct-to-patient (DTP) care models are rapidly reshaping healthcare delivery. As therapies increasingly move outside traditional clinical settings, pharmaceutical companies require drug delivery solutions that not only simplify self-administration but also create a connected ecosystem around the patient journey.
At the same time, the growing adoption of digital health, remote monitoring, decentralized clinical trials, and outcome-based care is creating demand for intelligent drug delivery platforms capable of generating high-quality therapy data while supporting patients in real time. This is particularly relevant for chronic therapies, including incretin-based treatments, where dose escalation, titration management, persistence, and long-term adherence are critical to achieving optimal outcomes.
Against this backdrop, SmartPilot for UnoPen is developed as a modular, reusable connected injection platform designed to support the future of direct-to-patient care, clinical research, and digital therapeutics. The platform vision extends beyond drug delivery to enable an integrated ecosystem that combines connected injection devices, patient support services, remote therapy monitoring, and data-driven treatment optimization.
Current development
The platform is currently in an advanced concept development phase, with preparations underway to initiate collaborations with pharmaceutical partners. Development is progressing according to plan, with flexibility to align timelines to specific partner programs and market strategies.
Interested in specific timelines for your project? Contact us to discuss partnership opportunities and tailored development schedules.
